Trial Profile
A Phase II Study Of Gleevec (Imatinib Mesylate Formerly Known as STI-571) In Patients With Myelofibrosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Myelofibrosis
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 06 Sep 2005 New trial record.